Central Cancer Registry Reporting Content IG, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-central-cancer-registry-reporting-ig/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
Profile: mCODE Cancer Related Medication Administration
status: completed
category: Outpatient
medication: rxnorm 72962 docetaxel
subject: Patient-example: Amy Shaw
start date: 2023-04-10
Performer: Joseph Nichols
reasonReference: Condition-primary-cancer-condition-breast
authoredOn: 2023-04-10
note: Chemotherapy regimen of docetaxel, carboplatin, adriamycin, cyclophosphamide, and paclitaxel administered by continuous infusion. Patient tolerated infusion without side effects.
Route: SNOMED 47625008 Intravenous route (qualifier value)